As COVID-19 cases reduce, there are still a few people with underlying medical conditions who are still prone to COVID-19 infection. For this reason, the US department of health and CDC has made it official that COVID-19 booster shots should be taken to avoid more spreading of the infection to other patients with the same underlying respiratory conditions. It is also mandatory that public and healthcare workers take booster shots as a preventive measure as they meet with more people on a daily basis. The new booster shots are Moderna bivalent and Pfizer-BioNTech’s bivalent boosters are recommended by the AMA.

1. New CPT codes for COVID-19 Booster
Vaccine
www.billingparadise.com
Visit Us

2. 01
COVID-19 and its adaptation are still a threat to many individuals
in the United States. The CDC has prioritized that people with
symptoms even after receiving the covid vaccines that work in
public domains, healthcare, and other high-population settings
must use these covid booster vaccines for safety measures for
themselves their loved ones, and the people surrounding them.
It is not because of the raising covid-19 conditions, but because of
safety concerns to stop the adaptation of a new strain of the
covid-19 virus. So many healthcare organizations such as The CDC,
WHO, AMA, and FDA have approved booster vaccine doses from a
few of the best biotech companies.
The AMA (American Medical Association) has declared newly
added and updated to its Current Procedural nomenclature (CPT)
code set to incorporate eight new codes for the bivalent COVID-19
vaccine doses from Moderna and Pfizer-BioNTech.

3. 02
The US Food and Drug Administration (FDA) amended the
emergency use authorizations for each Moderna’s and Pfizer-
BioNTech’s vaccines to authorize bivalent formulations to run as
one booster shot a minimum of 2 months following primary or
booster vaccination. The bivalent vaccines contain 2 RNA
components: one for the initial COVID-19 strain and therefore the
alternative for the additional common BA.4 and BA.5 subvariants
of the now-dominant letter of the alphabet strain.
The same day because of the FDA’s announcement, AMA
discharged the new CPT codes for the bivalent COVID-19 booster
doses therefore suppliers will document and bill for
administering boosters as presently because the vaccinum doses
will be on the market this fall.
Across the state, 108 million Americans or over half those eligible
to be boosted—have nevertheless to receive their initial booster
shot despite proof that they’re safe and extremely effective
against severe sickness outcomes.

4. 03
The consultatory Committee on immunization Practices should currently
review and approve the employment of the bivalent COVID-19 vaccinum doses.
The Committee is regularly to satisfy nowadays. Previous approvals for original
COVID-19 vaccines stirred fairly quickly, taking simply one or two weeks.
The AMA (American Medical Association) appearance forward to the review of
the redesigned COVID-19 boosters by the consultatory Committee on
Immunization Practices and its unfinished recommendations on clinical uses
for every product. As we have a tendency to inure potential fall and winter
surges of COVID-19, the AMA encourages all citizens will be eligible to induce a
booster and review the on-the-market choices with a doctor.
The new CPT codes embrace 91312, 91313, 0124A, and 0134A, which will be
effective to be used forthwith following the FDA’s change of the emergency
use authorization for Moderna’s new COVID-19 booster in folks that must be
eighteen years or older and Pfizer-BioNTech’s new COVID-19 booster in people
must be twelve years or older.
The other four new CPT codes— 91314, 91315, 0144A, and 0154A—will be
effectively to be used once Food and Drug Administration authorizes
Moderna’s new COVID-19 booster for youngsters between the ages of six and
eleven years and Pfizer-BioNTech’s new COVID-19 booster for youngsters
between five and eleven years.

5. 04
91314 – Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
(coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein,
bivalent, preservative-free, 25 mcg/0.25 mL dosage, for intramuscular use
0144A – Immunization administration by intramuscular injection of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus
disease [COVID-19]) vaccine, mRN-LNP, spike protein, bivalent,
preservative-free, 25 mcg/0.25 mL dosage, a booster dose
Moderna bivalent boosters for children
codes and descriptions

6. 05
91313 – Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
(coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein,
bivalent, preservative-free, 50 mcg/0.5 mL dosage, for intramuscular use
0134A – Immunization administration by intramuscular injection of
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
(coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein,
bivalent, preservative-free, 50 mcg/0.5 mL dosage, a booster dose
Moderna bivalent boosters for adults
codes and descriptions

7. 06
91315 – Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
(coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike
protein, preservative-free, 10 mcg/0.2 mL dosage, diluent reconstituted,
tris-sucrose formulation, for intramuscular use.
0154A – Immunization administration by intramuscular injection of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus
disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein,
preservative-free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-
sucrose formulation, booster dose
Pfizer-BioNTech’s bivalent COVID-19 boosters
for children codes and descriptions

8. 07
91312 – Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
(coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike
protein, preservative-free, 30 mcg/0.3 mL dosage, tris-sucrose formulation,
for intramuscular use.
0124A – Immunization administration by intramuscular injection of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus
disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein,
preservative-free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, booster
dose.
Pfizer-BioNTech’s bivalent booster in
individuals 12 years or older codes and
descriptions

9. 06
BillingParadise has already assisted many medical groups and practices to bill
for the covid-19 screening, vaccination administration, etc, and has helped
them receive reimbursement. Billing for covid-19 cases and inpatient stay is
complicated. It is wise for healthcare facilities and medical practices to
consult experts that have already done and succeeded in this billing and then
proceed. For practices that require enrolment in the provider relief fund,
BillingParadise can definitely assist. Schedule a free consultation now!
Website www.billingparadise.com
inquiries@billingparadise.com
+1 888-571-9069
Email
Phone
Address BillingParadise 24x7 INC 53
Emerald Road, Robbinsville,
NJ 08691. United States.
Contact us